BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«KATP Channels

Below is an extended KATP Channels research listing. Click here to return to the KATP Channels main in depth entry.

Recent Publications on KATP Channels:

Regulation of KATP channel expression and activity by the SUR1 nucleotide binding fold 1. 3rd October, 2008
Department of Cell Biology and Physiology, Washington University School of
Roles of phosphatidylinositol 3-kinase-Akt and NADPH oxidase in adenosine 5'-triphosphate-sensitive K+ channel function impaired by high glucose in the human artery.
The present study was designed to examine roles of the...
Direct Link
23rd September, 2008
Department of Anesthesiology, Wakayama Medical University, Wakayama,
Disruption of Sarcolemmal ATP-Sensitive Potassium Channel Activity Impairs the Cardiac Response to Systolic Overload.
Sarcolemmal ATP-sensitive potassium channels (KATP) act as metabolic...
Direct Link
20th September, 2008
Cardiovascular Division, and Vascular Biology Center, Department of
Association of the Kir6.2 E23K Variant with Reduced Acute Insulin Response in African Americans.
Context: ATP-sensitive potassium (KATP) channels are composed of...
Direct Link
18th September, 2008
Department of Biochemistry, Department of Internal Medicine, Department of
Glucose controls cytosolic Ca2+ and insulin secretion in mouse islets lacking ATP-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.
Glucose-induced insulin secretion is classically attributed to the...
Direct Link
13th September, 2008
Unit of Endocrinology and Metabolism (M.A.R., M.N., J.C.H.), University of
Chronic Sustained and Intermittent Hypoxia Reduce the Function of ATP-Sensitive Potassium Channels in the Nucleus of the Solitary Tract.
Activation of neuronal ATP-sensitive potassium (KATP) channels is an...
Direct Link
12th September, 2008
University of Texas Health Science Center at San Antonio.
Insulin-like growth factor-I inhibits rat arterial K(ATP) channels through pI 3-kinase.
Since, in addition to its growth-promoting actions, insulin-like growth...
Direct Link
11th September, 2008
Department of Cell Physiology and Pharmacology, Ion Channel Group,
Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. 2nd September, 2008
Department of Pharmaceutical Sciences and Drug Research, Punjabi
Coassembly of Different Sulfonylurea Receptor Subtypes Extends the Phenotypic Diversity of ATP-sensitive Potassium (KATP) Channels.
KATP channels are metabolic sensors and targets of potassium channel...
Direct Link
30th August, 2008
Case Western Reserve University.
Intravenous adenosine reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel. 30th August, 2008
Fu-Wai Heart Hospital, Beijing, People's Republic of China.
Functional clustering of mutations in the dimer interface of the nucleotide binding folds of the sulfonylurea receptor.
ATP-sensitive K+ (KATP) channels modulate their activity as a function of...
Direct Link
22nd August, 2008
Cell Biology and Physiology, Washington University, St. Louis, MO 63110.
A DEND mutation in Kir6.2 (KCNJ11) reveals a flexible N-terminal region critical for ATP-sensing of the KATP channel.
ATP-sensitive K(+)-channels link metabolism and excitability in neurons,...
Direct Link
19th August, 2008
Washington University School Medicine.
Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.
Astrocyte activation observed in the MPTP mouse model and Parkinson's...
Direct Link
14th August, 2008
Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology,
Calmodulin kinase II inhibition enhances ischemic preconditioning by augmenting ATP-sensitive K+ current. 12th August, 2008
Departments of Medicine, Carver College of Medicine, University of Iowa,
Embryonic Stem Cell Therapy of Heart Failure in Genetic Cardiomyopathy.
Pathogenic causes underlying non-ischemic cardiomyopathies are...
Direct Link
2nd August, 2008
Marriott Heart Disease Research Program, Division of Cardiovascular
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional